Biomarin Pharmaceutical (BMRN) Prepaid Assets (2009 - 2026)

Biomarin Pharmaceutical (BMRN) has 18 years of Prepaid Assets data on file, last reported at $205.5 million in Q1 2026.

• Quarterly Prepaid Assets rose 13.2% year-over-year to $205.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $205.5 million (up 13.2% YoY) and the FY2025 annual result came in at $185.8 million, down 7.81% from the prior year.
• Prepaid Assets grew to $205.5 million in Q1 2026, from $185.8 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $224.8 million in Q3 2023 to a low of $104.5 million in Q4 2022.
• A 5-year average of $170.4 million and a median of $173.2 million in 2023 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2023 — Prepaid Assets surged 50.02% — and 2024, when it fell 24.71%.
• Tracing BMRN's Prepaid Assets over 5 years: stood at $104.5 million in 2022, then jumped by 35.28% to $141.4 million in 2023, then jumped by 42.54% to $201.5 million in 2024, then slipped by 7.81% to $185.8 million in 2025, then gained by 10.61% to $205.5 million in 2026.
• The last three Prepaid Assets figures came in at $205.5 million (Q1 2026), $185.8 million (Q4 2025), and $204.3 million (Q3 2025), per Business Quant data.